A detailed history of Park Avenue Securities LLC transactions in Novartis Ag stock. As of the latest transaction made, Park Avenue Securities LLC holds 32,851 shares of NVS stock, worth $3.19 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
32,851
Previous 34,482 4.73%
Holding current value
$3.19 Million
Previous $3.67 Million 2.94%
% of portfolio
0.04%
Previous 0.04%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$106.13 - $120.89 $173,098 - $197,171
-1,631 Reduced 4.73%
32,851 $3.78 Million
Q2 2024

Jul 09, 2024

BUY
$92.57 - $107.37 $635,215 - $736,772
6,862 Added 24.84%
34,482 $3.67 Million
Q1 2024

Apr 10, 2024

SELL
$95.27 - $108.47 $428,905 - $488,331
-4,502 Reduced 14.02%
27,620 $2.67 Million
Q4 2023

Jan 10, 2024

BUY
$92.27 - $101.54 $188,138 - $207,040
2,039 Added 6.78%
32,122 $3.24 Million
Q3 2023

Oct 26, 2023

BUY
$94.73 - $105.13 $136,600 - $151,597
1,442 Added 5.03%
30,083 $3.06 Million
Q2 2023

Jul 14, 2023

BUY
$92.52 - $104.91 $464,080 - $526,228
5,016 Added 21.23%
28,641 $2.89 Million
Q1 2023

Apr 18, 2023

SELL
$80.03 - $92.81 $17,526 - $20,325
-219 Reduced 0.92%
23,625 $2.17 Million
Q4 2022

Jan 24, 2023

BUY
$75.55 - $92.52 $233,525 - $285,979
3,091 Added 14.89%
23,844 $0
Q3 2022

Nov 01, 2022

BUY
$74.61 - $87.26 $105,125 - $122,949
1,409 Added 7.28%
20,753 $1.58 Million
Q2 2022

Jul 27, 2022

BUY
$80.52 - $93.75 $225,617 - $262,687
2,802 Added 16.94%
19,344 $1.64 Million
Q1 2022

Apr 29, 2022

BUY
$80.11 - $90.62 $191,302 - $216,400
2,388 Added 16.87%
16,542 $1.45 Million
Q4 2021

Apr 08, 2022

SELL
$79.7 - $88.13 $123,056 - $136,072
-1,544 Reduced 9.84%
14,154 $1.24 Million
Q3 2021

Oct 21, 2021

BUY
$81.78 - $95.14 $66,568 - $77,443
814 Added 5.47%
15,698 $1.28 Million
Q2 2021

Aug 05, 2021

BUY
$85.24 - $94.15 $33,925 - $37,471
398 Added 2.75%
14,884 $1.36 Million
Q1 2021

Apr 28, 2021

BUY
$83.5 - $98.47 $12,274 - $14,475
147 Added 1.03%
14,486 $1.24 Million
Q4 2020

Jan 20, 2021

BUY
$78.07 - $94.43 $40,284 - $48,725
516 Added 3.73%
14,339 $1.35 Million
Q3 2020

Nov 03, 2020

BUY
$82.14 - $91.0 $56,183 - $62,244
684 Added 5.21%
13,823 $1.2 Million
Q2 2020

Jul 30, 2020

BUY
$80.93 - $91.1 $285,601 - $321,491
3,529 Added 36.72%
13,139 $1.15 Million
Q1 2020

Apr 28, 2020

BUY
$70.67 - $99.01 $32,084 - $44,950
454 Added 4.96%
9,610 $792,000
Q4 2019

Feb 04, 2020

BUY
$84.35 - $95.37 $103,160 - $116,637
1,223 Added 15.42%
9,156 $867,000
Q3 2019

Oct 18, 2019

BUY
$85.54 - $94.26 $127,711 - $140,730
1,493 Added 23.18%
7,933 $689,000
Q2 2019

Jul 26, 2019

BUY
$75.4 - $92.8 $94,551 - $116,371
1,254 Added 24.18%
6,440 $588,000
Q1 2019

May 02, 2019

BUY
$75.32 - $86.15 $131,282 - $150,159
1,743 Added 50.62%
5,186 $496,000
Q4 2018

Jan 29, 2019

BUY
$73.66 - $82.02 $43,827 - $48,801
595 Added 20.89%
3,443 $302,000
Q3 2018

Nov 05, 2018

SELL
$66.94 - $77.43 $24,566 - $28,416
-367 Reduced 11.42%
2,848 $246,000
Q2 2018

Jul 30, 2018

BUY
$64.91 - $73.36 $208,685 - $235,852
3,215 New
3,215 $240,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Park Avenue Securities LLC Portfolio

Follow Park Avenue Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Avenue Securities LLC with notifications on news.